The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Jun. 19, 2012
Applicants:

Lilin Zhang, Tokyo, JP;

Katsuyuki Mitomo, Tokyo, JP;

Katsushi Kouda, Tokyo, JP;

Yoko Kayukawa, Tokyo, JP;

Inventors:

Lilin Zhang, Tokyo, JP;

Katsuyuki Mitomo, Tokyo, JP;

Katsushi Kouda, Tokyo, JP;

Yoko Kayukawa, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 39/395 (2013.01); C07K 16/46 (2013.01); C12N 5/10 (2013.01); C12N 15/09 (2013.01); G01N 33/53 (2013.01);
Abstract

It is an object to provide a recombinant antibody that is an anti-CDH3 antibody having cytotoxicity on CDH3-expressing cells, which is anticipated to have fewer side effects than antibodies derived from animals other than humans and to maintain its therapeutic effects for a long period of time. The present invention provides a recombinant antibody which specifically reacts with an epitope existing in the amino acids at positions 108 to 131 or at positions 551 to 654 of the amino acid sequence shown in SEQ ID NO: 38 that is the extracellular region of human CDH3, and has cytotoxicity against CDH3-expressing cells.


Find Patent Forward Citations

Loading…